Table 2. Selectivity of Compounds on Cancer and Normal Cells.
| selectivity
(fold) |
||
|---|---|---|
| compounds | A549 vs BEAS-2B | H1975 vs BEAS-2B |
| compound 38 | 1.30 | 0.92 |
| compound 45 | 7.10 | 5.80 |
| doxorubicin | 0.39 | 3.47 |
| paclitaxel | 0.42 | 3.28 |
| selectivity
(fold) |
||
|---|---|---|
| compounds | A549 vs BEAS-2B | H1975 vs BEAS-2B |
| compound 38 | 1.30 | 0.92 |
| compound 45 | 7.10 | 5.80 |
| doxorubicin | 0.39 | 3.47 |
| paclitaxel | 0.42 | 3.28 |